Malignancy and recurrence phenomena include which signs?

Get ready for the Norton Certification Test. Study with comprehensive materials, quizzes, and expert insights. Enhance your skills and boost your exam readiness today!

Multiple Choice

Malignancy and recurrence phenomena include which signs?

Explanation:
Signs that point to malignancy and possible recurrence are those showing active tumor effects on the body, such as new or worsening pain, impaired function, and visible changes to the skin. Pain reflects ongoing tumor activity or pressure on nerves and tissues, while loss of function indicates the tumor is disrupting normal abilities in the affected area. Skin changes like shininess can arise from edema, fibrosis, or direct involvement of the skin, signaling a local process related to the malignancy. Hair loss and nail changes are more commonly side effects of treatments like chemotherapy than direct signs of the tumor itself. Nausea and dizziness also tend to come from treatment or systemic illness rather than indicating recurrence. Weight gain is not typically a hallmark of malignancy or its return; weight loss is more commonly associated with cancer progression.

Signs that point to malignancy and possible recurrence are those showing active tumor effects on the body, such as new or worsening pain, impaired function, and visible changes to the skin. Pain reflects ongoing tumor activity or pressure on nerves and tissues, while loss of function indicates the tumor is disrupting normal abilities in the affected area. Skin changes like shininess can arise from edema, fibrosis, or direct involvement of the skin, signaling a local process related to the malignancy.

Hair loss and nail changes are more commonly side effects of treatments like chemotherapy than direct signs of the tumor itself. Nausea and dizziness also tend to come from treatment or systemic illness rather than indicating recurrence. Weight gain is not typically a hallmark of malignancy or its return; weight loss is more commonly associated with cancer progression.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy